西部材料(002149.SZ):擬與西部超導分別認購金鈦股份1200萬股 投資後持股比例為8%
格隆匯 9 月 28日丨西部材料(002149.SZ)公告,公司擬與關聯方西部超導材料科技股份有限公司(以下簡稱:“西部超導”)共同投資參股朝陽金達鈦業股份有限公司(以下簡稱:“金鈦股份”),通過增資方式認購1200萬股,投資金額4752萬元,投資後持股比例為8%。
根據《深圳證券交易所股票上市規則》及《公司章程》規定,本次關聯交易在公司董事會審批範圍內,無需提交公司股東大會審議。
西部超導和西部材料的控股股東同為西北有色金屬研究院,構成關聯交易,但不構成重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.